Category: Gavinchuk
-
What are psychedelics companies like Psyense (PSYG.C), Havn (HAVN.C), Canbud (CBDX.C) and Field Trip (FTRP.C) all doing in Jamaica?
Shroom tea Jamaica is one of the few countries in the world where the sale and consumption of psilocybin is legal, and through my DD, it’s incredibly easy to attain. The country isn’t new to foreigners tripping there, tourists have been visiting the island for decades for its famous magic mushroom teas. For people who…
-
My dumbest trade ever was during an IPO
As far back as I can remember, I always wanted to be a trader I remember when I first started buying stocks, I was 16 using a family member’s trading account with their permission. I didn’t have a cellphone, so I lived in the school library checking my stonks. My teachers thought I was burnout…
-
How Cybin (CYBN.NE) is integrating new brain imaging technology with psychedelics
Shamans among the machines In his 1999 lecture titled ‘Shamans Among the Machines’ Terence McKenna pointed out that “as far as people and machines are concerned, it was Ludwig von Bertalanffy who said in his book General Systems Theory: ‘people are not machines, but in every opportunity where they are allowed to behave like machines,…
-
Revive Therapeutics (RVV.C) CEO Michael Frank likes the stock, buys the dip
+135k shares in a downturn, my man The psychedelics sector is down bad this week. Just look at the psychedelics ETF PSYK.NE. It’s not an alarm or anything, things have been running pretty nicely the past couple of quarters and it was probably time for a correction. Any time a sector emerges this quickly there…
-
How Field Trip (FTRP.CN) is scaling its ketamine therapy operations following a giant raise
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD but was later upsized to $82.9M CAD. It was priced at $6.50 CAD per share, adding 12.8M shares to the pool, bringing the number of shares…
-
Atai and Psybio: A closer look at two very different upcoming psychedelics IPO’s for 2021
IPO’s come in all shapes and sizes, some are giants with billionaire support, and others don’t have a pitch deck readily available. Investors get giddy with news of IPO’s as it signals a chance to get in early. It’s important to note that ‘getting in early’ isn’t a guarantee in an IPO, relatively speaking. Take…
-
Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again
Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come a long way, and in that process, questions have arisen like: how do money and psychedelics mix? Psychedelic medicine advocates who have never been around the…
-
What is the NEO exchange, and how is it making the stock market less scammy?
The Wild Wild West I was skeptical when I came across a new stock exchange I had never heard of before. Through reporting on the cannabis industry I saw how lenient certain exchanges were on a lot of the scams in the space, and there were many. The CSE and OTC exchanges especially became like…
-
Maricann (MARI.C)’s CEO not letting OSC investigation and delayed prospectus get in his way
Ontario-based cannabis cultivator Maricann Group has big plans. Despite ongoing expansions at the company facilities in Ontario and Germany both being “fully funded,” a pubco can always use some cash. Maricann reports selling dope produced in their Ontario facility consistently to the medical market. With the rec market right around the corner, destined to soak…
-
Aurora (ACB.T) breaks $7 support; ABcann (ABCN.V) acquires Canna Farms & launches sexy rec brand
Today Aurora Cannabis (ACB.T) closed at $6.81 CAD on 20.6 million shares traded. The is the first time Aurora has closed below the $7 support level since December 7th, 2017. It bounced off of that support level in February, April, and May, going on trough-to-peak runs of 59%, 29.3% and 46% respectively, each time it…